Screening for Hepatic Fibrosis Using an Automatically Calculated FIB-4 Score in Patients with Type 2 Diabetes: A Single-Center Study.
BACKGROUND Patients with type 2 diabetes (T2D) are at high risk of metabolic dysfunction-associated steatotic liver disease, which may progress to advanced fibrosis but remains underdiagnosed in routine clinical practice. Automated laboratory-based tools may improve early identification of at-risk patients. METHODS W...